Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer

BCG therapy is used as a treatment in bladder cancer. Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is commonly effective, some serious side effects may occur. We hereby report a 65-year-old man who developed granulomato...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayati, Mohsen, Nowroozi, Mohammad Reza, Mortazavi, Afshin, Ohadian Moghadam, Solmaz, Ghorani, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447372/
https://www.ncbi.nlm.nih.gov/pubmed/28567336
http://dx.doi.org/10.1016/j.eucr.2017.04.011
Descripción
Sumario:BCG therapy is used as a treatment in bladder cancer. Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is commonly effective, some serious side effects may occur. We hereby report a 65-year-old man who developed granulomatous hepatitis as a complication following BCG therapy. He was treated successfully with antitubercular therapy and prednisolone.

Ejemplares similares